Member Info for Slacker246

Major holding from a share issue of

543,140 ,000

😂😂😂

Waynesmith

Facts are facts

Have you seen the share price!?

Have you seen total annual company income!?

How about the £400k to £600k monthly cashburn

Just remind me of the Institutional investors!

There on the clock

Tic toc 🔻

It is blatantly obvious that there are NO sales as nobody wants it or needs it, lab testing is the preferred choice as per NICE recommendation!!

Very plain to see why NICE recommendation is to continue with existing lab testing!!

what hospital manager will disagree, they will just follow the guidance, that's what there paid to do!!

nobody wants it and nobody needs it!

will it join Genedrives list of legacy products??

105 hospitals in England provide pathology services.

NICE recommendation.

Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

Facts from NHS England

Around 95% of clinical pathways rely on patients having access to pathology services.

500 million biochemistry and 130 million haematology tests are carried out per year.

14 tests for each person in England and Wales are performed annually.

300,000 tests are performed every working day.

50 million reports are sent from labs to GPs every year.

NICE disagree.....sorry!

Hospital managers that grip the purse strings tightly will follow NICE recommendations....lab testing it is!!

Will Genedrive join SDRY snd DEST to name but a few over on JP Jenkins.....it is a real possibility!!!

Will Genedtivd join SDY snd DEST tk nsmd but z few over on JP Jenkins.....it is a real possibility!!!

Just wondering where it states NICE approval on flyer???

Why is it going to rocket....pray tell??

Oh dear potty mouth!

Counter opinion would be more beneficial to potential investors...don't you think!?

Genedrive website has not even been updated to show NICE approval for CYP2C19

WTF!!!!

Of that 25% what percentage have defective gene!

Risk vs benefit vs cost

1 in 4 people have a second stroke!!

CYP2C19

Nobody needs it or wants it!

Simples!

No institutional investors

Dumb money averaging down to escape

Very limited GDR board investment

Cheeky departed without explanation

Cheeky refused to answer question on taking GDR private during last presentation.

NICE recommends lab testing over CYP2C19

Outrageous monthly cashburn £400K to £600K

Negligible very limited company income

Recent maahoosive share dilution to give £6million

No real take up of either AIHL or CYP2C19 in NHS

Share price dripping away to placing price and below

Comek2

Of course your in this to save lives and not line you pockets!

Line your pockets.......we shall see??

😂😂😂😂😂

No volume and no interest!